MOLECULAR EFFECTS OF EARLY EXPERIENCE ON MOTOR NEURON
MOLECULAR EFFECTS OF EARLY EXPERIENCE ON MOTOR NEURON
批准号:
3084082
负责人:
Robert G Kalb
金额:
$8.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-07-01 至 1992-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
During critical periods in neural development, the structure and
function of the CNS can be profoundly influenced by an organism's
interactions with its environment. In cats for example, the
formation of normal lamination patterns in the dorsal lateral
geniculate nucleus (LGN) and of ocular dominance columns in the
striate cortex require normal early visual experience. In addition
to anatomical and physiological changes, molecular
characteristics of neurons are also sensitive to early visual
experience. Monoclonal antibody Cat-301 recognizes an antigen
on LGN Y-cells whose expression is tied to normal visual
experience early in life. Monocular lid suture at birth not only
inhibits the physiological and morphological development of Y-
cells in the deprived layers of the LGN, but also the expression of
the Cat-301 antigen on the same cells. After the critical period,
monocular lid suture does not effect Y-cell morphology or
physiology and likewise the Cat-301 antigen is unaffected. These
findings suggest that the expression of the Cat-301 antigen
provides a positive molecular marker for critical period events in
visual system development.
Our recent work indicates that Cat-301 is expressed on spinal
cord motor neurons of hamsters in an experience-dependent
manner. Just as Cat-301 expression on Y-cells is tied to normal
early visual experience, its expression on hamster motor neurons
is tied to normal neuromuscular experience in early life.
Manipulating the neuromuscular environment in maturity has no
effect on Cat-301 expression, indicating that its expression is not
simply activity-dependent.
Here we propose studies using the hamster spinal cord system to
study experience-dependent features of development. This
system presents many advantages for studying the neural activity
that contributes to normal development as the motor unit is
amenable to pharmacologic dissection, ultrastructural analysis
and in vitro manipulation. Pharmacological studies will test the
contribution of the components of the motor unit to development
using a-bungarotoxin, colchicine and tetrodotoxin. EM studies
will correlate ultrastructural events in synaptogenesis with Cat-
301 expression and critical period phenomena. A motor neuron
culture system will be developed to confirm and extend this
analysis. Finally, since Cat-301 is expressed on human motor
neurons, we will attempt to define a developmental critical period
for human motor neurons by assaying Cat-301 expression in human
autopsy material of various ages.
These studies are designed to increase our understanding of
experience-dependent development. This knowledge may have
important implications for functional recovery after injury in the
developing and adult human CNS.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Molecular evidence for early activity-dependent development of hamster motor neurons.
仓鼠运动神经元早期活动依赖性发育的分子证据。
DOI:
10.1523/jneurosci.08-07-02350.1988
发表时间:
1988
期刊:
The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子:
--
作者:
[Kalb,RG, Hockfield,S]
通讯作者:
Hockfield,S
Large diameter primary afferent input is required for expression of the Cat-301 proteoglycan on the surface of motor neurons.
Cat-301 蛋白多糖在运动神经元表面的表达需要大直径的初级传入输入。
DOI:
10.1016/0306-4522(90)90148-w
发表时间:
1990
期刊:
Neuroscience
影响因子:
3.3
作者:
[Kalb,RG, Hockfield,S]
通讯作者:
Hockfield,S
Defining mechanisms underlying C9orf72-associated frontotemporal dementia with C. elegans and mammalian models
-
批准号:10552038
-
项目类别:
-
资助金额:$74.57万
-
财政年份:2022
-
负责人:Robert G Kalb
-
依托单位:
Defining mechanisms underlying C9orf72-associated frontotemporal dementia with C. elegans and mammalian models
-
批准号:10342721
-
项目类别:
-
资助金额:$76.69万
-
财政年份:2022
-
负责人:Robert G Kalb
-
依托单位:
RAD23 Control of ALS phenotypes
-
批准号:10406184
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2021
-
负责人:Robert G Kalb
-
依托单位:
RAD23 Control of ALS phenotypes
-
批准号:10617853
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2021
-
负责人:Robert G Kalb
-
依托单位:
RAD23 Control of ALS phenotypes
-
批准号:10274489
-
项目类别:
-
资助金额:$39.88万
-
财政年份:2021
-
负责人:Robert G Kalb
-
依托单位:
AMPK, metabolism and ALS
-
批准号:9621133
-
项目类别:
-
资助金额:$8.4万
-
财政年份:2018
-
负责人:Robert G Kalb
-
依托单位:
Cytohesins, ARF GTP'ases and Neurodegeneration
-
批准号:9605921
-
项目类别:
-
资助金额:$8.4万
-
财政年份:2017
-
负责人:Robert G Kalb
-
依托单位:
AMPK, metabolism and ALS
-
批准号:9244083
-
项目类别:
-
资助金额:$38.69万
-
财政年份:2016
-
负责人:Robert G Kalb
-
依托单位:
AMPK, metabolism and ALS
-
批准号:9114785
-
项目类别:
-
资助金额:$49.29万
-
财政年份:2016
-
负责人:Robert G Kalb
-
依托单位:
Cytohesins, ARF GTP'ases and Neurodegeneration
-
批准号:9275554
-
项目类别:
-
资助金额:$12.6万
-
财政年份:2016
-
负责人:Robert G Kalb
-
依托单位:
ERAD genes that suppress neurodegeneration
-
批准号:8821999
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2014
-
负责人:Robert G Kalb
-
依托单位:
Identification of the endogenous ligand of SAP97 PDZ3
-
批准号:8606782
-
项目类别:
-
资助金额:$20.73万
-
财政年份:2013
-
负责人:Robert G Kalb
-
依托单位:
Identification of the endogenous ligand of SAP97 PDZ3
-
批准号:8507422
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2013
-
负责人:Robert G Kalb
-
依托单位:
Spatio-temporal control of FOXO3
-
批准号:8307681
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2012
-
负责人:Robert G Kalb
-
依托单位:
Spatio-temporal control of FOXO3
-
批准号:8445215
-
项目类别:
-
资助金额:$19.79万
-
财政年份:2012
-
负责人:Robert G Kalb
-
依托单位:
Energy Balance and Neurodegenerative Disease
-
批准号:8371374
-
项目类别:
-
资助金额:$20.94万
-
财政年份:2012
-
负责人:Robert G Kalb
-
依托单位:
Energy Balance and Neurodegenerative Disease
-
批准号:8465927
-
项目类别:
-
资助金额:$24.25万
-
财政年份:2012
-
负责人:Robert G Kalb
-
依托单位:
Pathological retrograde signaling in ALS
-
批准号:7916362
-
项目类别:
-
资助金额:$24.43万
-
财政年份:2009
-
负责人:Robert G Kalb
-
依托单位:
Abnormal Energy Homeostasis in ALS
-
批准号:7529077
-
项目类别:
-
资助金额:$17.99万
-
财政年份:2008
-
负责人:Robert G Kalb
-
依托单位:
Trophic Factor Signaling and Motor Neuron Death
-
批准号:8787803
-
项目类别:
-
资助金额:$36.64万
-
财政年份:2006
-
负责人:Robert G Kalb
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: